Formidable Asset Management’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Formidable Asset Management’s Portfolio HZNP Stock Details HZNP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-4,722	Closed	-$514K	–	335
2023 Q1	$514K	Sell	4,722 -1,900	-29%	-$210K	0.11%	175
2022 Q4	$754K	Buy	+6,622	New	+$550K	0.17%	113
2022 Q2	–	Sell	-8,678	Closed	-$913K	–	362
2022 Q1	$913K	Buy	+8,678	New	+$846K	0.18%	108
2021 Q4	–	Sell	-8,500	Closed	-$931K	–	365
2021 Q3	$931K	Sell	8,500 -290	-3%	-$30.1K	0.17%	109
2021 Q2	$822K	Sell	8,790 -75	-0.8%	-$6.9K	0.18%	111
2021 Q1	$802K	Buy	8,865 +230	+3%	+$19.4K	0.17%	118
2020 Q4	$626K	Buy	8,635 +775	+10%	+$57.6K	0.15%	130
2020 Q3	$627K	Sell	7,860 -40	-0.5%	-$2.75K	0.18%	110
2020 Q2	$450K	Sell	7,900 -1,100	-12%	-$47.1K	0.13%	148
2020 Q1	$267K	Buy	+9,000	New	+$304K	0.11%	149
2018 Q4	–	Sell	-12,725	Closed	-$241K	–	114
2018 Q3	$241K	Buy	+12,725	New	+$242K	0.09%	101
2017 Q4	–	Sell	-11,350	Closed	-$144K	–	221
2017 Q3	$144K	Buy	+11,350	New	+$144K	0.06%	191

Other funds holding HZNP

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $16.4B AUM 55.44% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

HBK Investments Dallas, Texas $10.2B AUM 67.73% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Formidable Asset Management's HZNP Position: Q2 2023 in Review

Formidable Asset Management sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q2 2023, closing a stake of 4,722 shares — an estimated $514K sold.

Formidable Asset Management first reported a position in HZNP in Q3 2017 and held it in 12 quarters. The position peaked at $931K in Q3 2021. 517 funds tracked by Wall St. Rank hold HZNP as of Q2 2023.

Formidable Asset Management reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q2 2023 after selling out during the quarter.
Formidable Asset Management sold 4,722 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q2 2023, an estimated $514K.
Formidable Asset Management first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q3 2017 and held it in 12 quarters.
Formidable Asset Management's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $931K in Q3 2021.
517 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q2 2023.

Based on Formidable Asset Management's 13F filing for Q2 2023, filed 15 Aug 2023.